Catalyst Wire Dossier Catalyst Wire Dossier

ADREVIEW

IOBENGUANE I-123 · Medi-Physics Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for ADREVIEW, covering 2008-09-19 to 2020-03-05. Get the full timeline:

Most recent: FDA Approved: ADREVIEW — Supplemental Application (Medi-Physics Inc.)

See pricing